Source:http://linkedlifedata.com/resource/pubmed/id/19351632
Switch to
Predicate | Object |
---|---|
rdf:type | |
lifeskim:mentions | |
pubmed:issue |
5
|
pubmed:dateCreated |
2009-4-29
|
pubmed:abstractText |
We studied the C-reactive protein level and its predictive value for early and late arrhythmia recurrences after atrial fibrillation (AF) ablation. We analysed data from 125 consecutive patients (52% with paroxysmal AF) who underwent a first AF ablation. C-reactive protein level was determined at baseline and at Days 1, 2, and 3 post-AF ablation. An early recurrence (ER) was defined as any arrhythmia occurring within the first month following the index ablation. Sixty-eight patients (54%) experienced ER. Twenty-nine patients were re-ablated for ER within the first month and were not included for the long-term follow-up analysis. Of the remaining 96 patients, 59 (61%) experienced late recurrences. C-reactive protein level increased significantly after AF ablation with a peak (40 +/- 32 mg/L) occurring 2 days after the index procedure. Patients without ER had a significant higher C-reactive protein level (49 +/- 52 vs. 32 +/- 22 mg/L, P=0.02) compared with patients without ER. However, the C-reactive protein level was similar in patients with or without late recurrences. C-reactive protein level was the only independent predictor of ERs (P = 0.03). C-reactive protein level increased significantly after AF ablation. High C-reactive protein level was associated with fewer early arrhythmia recurrences. No relationship was found between C-reactive protein level and late arrhythmia recurrences.
|
pubmed:language |
eng
|
pubmed:journal | |
pubmed:citationSubset |
IM
|
pubmed:chemical | |
pubmed:status |
MEDLINE
|
pubmed:month |
May
|
pubmed:issn |
1532-2092
|
pubmed:author |
pubmed-author:BrottierJeanJ,
pubmed-author:HaïssaguerreMichelM,
pubmed-author:HociniMéLèZeM,
pubmed-author:JaïsPierreP,
pubmed-author:KnechtSébastienS,
pubmed-author:LelloucheNicolasN,
pubmed-author:LomasOliverO,
pubmed-author:MatsuoSeiichiroS,
pubmed-author:NaultIsabelleI,
pubmed-author:SacherFredericF,
pubmed-author:WrightMatthewM
|
pubmed:issnType |
Electronic
|
pubmed:volume |
11
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
662-4
|
pubmed:meshHeading |
pubmed-meshheading:19351632-Adult,
pubmed-meshheading:19351632-Aged,
pubmed-meshheading:19351632-Atrial Fibrillation,
pubmed-meshheading:19351632-Biological Markers,
pubmed-meshheading:19351632-C-Reactive Protein,
pubmed-meshheading:19351632-Catheter Ablation,
pubmed-meshheading:19351632-Female,
pubmed-meshheading:19351632-Follow-Up Studies,
pubmed-meshheading:19351632-Humans,
pubmed-meshheading:19351632-Male,
pubmed-meshheading:19351632-Middle Aged,
pubmed-meshheading:19351632-Multivariate Analysis,
pubmed-meshheading:19351632-Predictive Value of Tests,
pubmed-meshheading:19351632-Prognosis,
pubmed-meshheading:19351632-Recurrence,
pubmed-meshheading:19351632-Retrospective Studies
|
pubmed:year |
2009
|
pubmed:articleTitle |
Usefulness of C-reactive protein in predicting early and late recurrences after atrial fibrillation ablation.
|
pubmed:affiliation |
Hôpital Henri Mondor Fédération de Cardiologie, Assistance Publique Hôpitaux de Paris, Université de Médecine Paris XII, Créteil, France. nicolellouche@yahoo.com
|
pubmed:publicationType |
Journal Article,
Research Support, Non-U.S. Gov't
|